Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cencora (COR) Capital Expenditures (2016 - 2025)

Cencora (COR) has disclosed Capital Expenditures for 17 consecutive years, with $119.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 12.73% year-over-year to $119.4 million, compared with a TTM value of $681.5 million through Dec 2025, up 31.34%, and an annual FY2025 reading of $668.0 million, up 37.11% over the prior year.
  • Capital Expenditures was $119.4 million for Q4 2025 at Cencora, down from $249.8 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $249.8 million in Q3 2025 and bottomed at $74.2 million in Q4 2023.
  • Average Capital Expenditures over 5 years is $130.1 million, with a median of $118.6 million recorded in 2024.
  • The sharpest move saw Capital Expenditures decreased 20.67% in 2023, then surged 55.43% in 2025.
  • Year by year, Capital Expenditures stood at $79.7 million in 2021, then dropped by 4.97% to $75.7 million in 2022, then decreased by 1.99% to $74.2 million in 2023, then soared by 42.68% to $105.9 million in 2024, then grew by 12.73% to $119.4 million in 2025.
  • Business Quant data shows Capital Expenditures for COR at $119.4 million in Q4 2025, $249.8 million in Q3 2025, and $183.2 million in Q2 2025.